157 related articles for article (PubMed ID: 26331342)
1. Characterization of a Case of Pigmentary Retinopathy in Sanfilippo Syndrome Type IIIA Associated with Compound Heterozygous Mutations in the SGSH Gene.
Wilkin J; Kerr NC; Byrd KW; Ward JC; Iannaccone A
Ophthalmic Genet; 2016 Jun; 37(2):217-27. PubMed ID: 26331342
[TBL] [Abstract][Full Text] [Related]
2. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
[TBL] [Abstract][Full Text] [Related]
3. Compound Heterozygous Mutations in ZNF408 in a Patient with a Late Onset Pigmentary Retinopathy and Relatively Preserved Central Retina.
Nadelmann JB; O'Neil EC; Kim DS; Juusola J; Aleman TS
Doc Ophthalmol; 2021 Dec; 143(3):305-312. PubMed ID: 34259982
[TBL] [Abstract][Full Text] [Related]
4. Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.
Seok S; Lyu IJ; Park KA; Oh SY
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2111-9. PubMed ID: 25690978
[TBL] [Abstract][Full Text] [Related]
5. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N
Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA.
Tanwar H; Kumar DT; Doss CGP; Zayed H
Metab Brain Dis; 2019 Dec; 34(6):1577-1594. PubMed ID: 31385193
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
8. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.
Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV
Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731
[TBL] [Abstract][Full Text] [Related]
9. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
[TBL] [Abstract][Full Text] [Related]
10. Childhood cone-rod dystrophy with macular cystic degeneration from recessive CRB1 mutation.
Khan AO; Aldahmesh MA; Abu-Safieh L; Alkuraya FS
Ophthalmic Genet; 2014 Sep; 35(3):130-7. PubMed ID: 23767994
[TBL] [Abstract][Full Text] [Related]
11. An Engineered
Douek AM; Amiri Khabooshan M; Henry J; Stamatis SA; Kreuder F; Ramm G; Änkö ML; Wlodkowic D; Kaslin J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073041
[TBL] [Abstract][Full Text] [Related]
12. Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.
De Falco A; Karali M; Criscuolo C; Testa F; Barillari MR; Scarpato M; Gaudieri V; Cuocolo A; Russo A; Nigro V; Simonelli F; Banfi S; Brunetti-Pierri N
Am J Med Genet A; 2024 May; 194(5):e63517. PubMed ID: 38149346
[TBL] [Abstract][Full Text] [Related]
13. Gene symbol: SGSH. Disease: Sanfilippo type A syndrome, mucopolysaccharidosis IIIA.
Di Natale P; Pontarelli G; Villani GR; Di Domenico C
Hum Genet; 2006 Jul; 119(6):679. PubMed ID: 17128482
[No Abstract] [Full Text] [Related]
14. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
16. A multiparametric computational algorithm for comprehensive assessment of genetic mutations in mucopolysaccharidosis type IIIA (Sanfilippo syndrome).
Ugrinov KG; Freed SD; Thomas CL; Lee SW
PLoS One; 2015; 10(3):e0121511. PubMed ID: 25807448
[TBL] [Abstract][Full Text] [Related]
17. Fundus albipunctatus associated with compound heterozygous mutations in RPE65.
Schatz P; Preising M; Lorenz B; Sander B; Larsen M; Rosenberg T
Ophthalmology; 2011 May; 118(5):888-94. PubMed ID: 21211845
[TBL] [Abstract][Full Text] [Related]
18. Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse-Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse.
Boado RJ; Lu JZ; Hui EK; Pardridge WM
Mol Pharm; 2018 Feb; 15(2):602-608. PubMed ID: 29251941
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.
Ritter M; Vodopiutz J; Lechner S; Moser E; Schmidt-Erfurth UM; Janecke AR
Br J Ophthalmol; 2013 Feb; 97(2):169-73. PubMed ID: 23143909
[TBL] [Abstract][Full Text] [Related]
20. High-resolution optical coherence tomography imaging in KCNV2 retinopathy.
Sergouniotis PI; Holder GE; Robson AG; Michaelides M; Webster AR; Moore AT
Br J Ophthalmol; 2012 Feb; 96(2):213-7. PubMed ID: 21558291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]